GSK fined for Indian drug pricing; Modular bioprocess plants use shipping containers;

> GSK has been fined about $16 million by India's Supreme Court in a drug pricing dispute. Item

> Biologics Modular has developed a modular system for bioprocess facility construction based on intermodal shipping containers. News

> Xcellerex sees validation of its single-use bioreactor technology for vaccine production in the positive Phase 1 results from its XRX-001 investigational vaccine for Yellow Fever. Xcellerex release

> Former Genzyme CEO Henri Termeer has joined the board of directors at AVEO Pharmaceuticals. Story

> West Pharmaceutical Services ramping up manufacturing capacity for the Daikyo Crystal Zenith 1-mL syringe system. West release

> GEA Pharma Systems has acquired freeze-drying specialist Beijing Sino-German Tianhe Technology. Article

> Freedonia projects a boost in demand for high-value-added packaging containers and accessories, thanks to upgraded regulations for infection control and patient compliance. Story

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.